The Cochrane Prostatic Diseases and Urologic Cancers Review Group, established in 1996, is based in the Minneapolis VA Center for Chronic Disease Outcomes Research (CCDOR) and the Division of Oncology at Velindre Hospital, Cardiff, Wales. Our group’s mission is to conduct and disseminate systematic reviews of health care interventions for prostatic diseases and urologic cancers. Evidence is primarily from randomized controlled trials.
The Prostatic Diseases and Urologic Cancers Review Group can also facilitate and provide valuable assistance for identification of topics and completion of reviews in a wide range of health care conditions.
Cochrane Colloquium
Keystone, Colorado, 18-22 October 2010
Singapore Colloquium
Past & future colloquia here.
|
|
|
Regularly updated evidence-based healthcare databases |